Who is sponsoring NCT06026150?

NCT06026150 is sponsored by Rashid Hospital.

What drugs are being tested in NCT06026150?

Interventions in NCT06026150: Ultrasound scanning of inguinal area for femoral nerve and artery.

What condition does NCT06026150 study?

NCT06026150 studies Femoral Fractures.

Is NCT06026150 still recruiting?

NCT06026150 is currently completed. Last updated 6 September 2023.

Last reviewed 2023-09-06 · How we verify

NCT06026150

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anatomical Variations of Femoral Nerve Location in Relation to Femoral Artery

Completed Last updated 6 September 2023

What this trial tests

trial testing Ultrasound scanning of inguinal area for femoral nerve and artery in Femoral Fractures in 200 participants. Completed in 15 August 2021.

Timeline

10 April 2016

Primary endpoint
30 November 2020

15 August 2021

Quick facts

Lead sponsor	Rashid Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	10 April 2016
Primary completion	30 November 2020
Estimated completion	15 August 2021

Drugs / interventions tested

Ultrasound scanning of inguinal area for femoral nerve and artery

Conditions studied

Femoral Fractures — all drugs for Femoral Fractures →

Sponsor

Rashid Hospital

Who can join

18 and older, any sex, with Femoral Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the relative position of femoral nerve in relation to the femoral artery in patients scheduled for femoral fractures using ultrasound scanning. The classical description of femoral nerve is that it lies immediately near to artery, but it is not always true. The nerve lies at a varying distance from the artery. The main question it aims to answer are: • Is the age sex and Body Mass Index affect the relationship between femoral artery and nerve?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06026150 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rashid Hospital
Last refreshed: 6 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06026150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing